Help us: Donate
Follow us on:
×

Menu

Back

Tag: Advocacy

Raiany Rommani
Raiany Romanni is a Harvard Kennedy Fellow in Effective Altruism, an A360 Scholar, a Stanford Existential Risk Fellow, and a bioethicist. She is currently working on a non-fiction book aimed at catalyzing the ethics of longevity research, while suggesting that aging is the costliest of all human diseases. You are a bioethicist. Could you explain...
Oil of Snake
It seems bizarre that in 2022, some biotech companies interested in doing something about aging are still saying that they are not. Cellular rejuvenation seems to be the latest buzzword and an attempt to rebrand and escape the stigma of anti-aging. Genentech is another cellular rejuvenation company Recently, researchers at the Salk Institute, in collaboration...
Debate
Eric Le Bourg has published a thought-provoking paper in Biogerontology that offers a critique of geroscience [1]. Geroscience, we need to talk... When people discuss the prospects of targeting the aging processes to prevent, halt, or even reverse age-related diseases, their beliefs often fall into two opposing categories. The first is overly optimistic blue-sky thinking,...
Sonia Arrison
Sonia Arrison is an entrepreneur, investor, and best-selling author. Her book “100 Plus: How the Coming Age of Longevity Will Change Everything”, published in 2011, was one of the first to bring the topic of longevity to the general public’s attention. Sonia is also founder of 100 Plus Capital and Chair of the Alliance for...
Some people are uneasy about the idea of extending human healthy lifespan by using rejuvenation technologies that target the aging process directly. Even people who accept the possibility that such therapies can be developed are not always convinced that developing them is a good idea. Interestingly enough there are only a few arguments that most...
AL4I Panel
A recent online discussion panel revealed some valuable insights into the political aspects of increasing healthy human lifespans. Perhaps the most exciting part of the panel involves the idea that getting politicians to support longevity/aging therapeutics might not be as hard as people may think. Giving our field an effective political voice On December 9th,...